News Archive - Page 3 of 8 - Meximp Technologies

Agilent Names John Palma to Lead Global Medical Affairs Organization

Agilent Names John Palma to Lead Global Medical Affairs Organization Agilent Technologies, Inc. (NYSE: A) today...

Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric,...

Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast...

GE Healthcare Debuts MyoSPECT, A Next-Generation Nuclear Medicine Cardiology System That Gets to the Heart of...

Start of the Magnetic Resonance Outcome (MRO) study to evaluate the ClearCoast™ MRI system The ClearCoast™ MRI...

New name: ClearSight™ has become ClearCoast™ ClearCut Medical Ltd. has changed the name of its...

A Deep-Learning Model May Help Predict Lung Cancer Survival and Outcomes A deep-learning model developed using...

Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement Agilent Technologies Inc. (NYSE: A)...

Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer PD-L1 IHC 22C3 pharmDx can now...

ESP Virtual Congress 2021 Milestone will participate to the 33nd European Congress of Pathology, from 29th to 31st...

Page 3 of 8